Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial

Share :
Published: 27 Apr 2015
Views: 2260
Rating:
Save
Prof Antoni Ribas - UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

Prof Ribas presents the findings of a phase III trial, which showed pembrolizumab to be preferable to ipilimumab in advanced melanoma, at a press conference at AACR 2015.

Read the news story for more or watch the interview for more.